Concepedia

Graeme Currie

GC

8

Publications

1.2K

Citations

8

H-Index

2002

Active since

Affiliations

Rainier Clinical Research Center(Current)

Gilead Sciences (United States)

The University of Texas MD Anderson Cancer Center

European Institute of Oncology

City of Hope

Graeme Currie is an author at Rainier Clinical Research Center specializing in medicine, urology, and oncology.

Top concepts

Publications per year

2002–2019

8

Publications

8

Long-Term Therapy with Adefovir Dipivoxil for HBeAg-Negative Chronic Hepatitis B

Stephanos J. Hadziyannis, Nicolaos C. Tassopoulos, E. Jenny Heathcote et al. · New England Journal of Medicine · 2005 · 535 citations · Full text

Peginterferon alpha-2b plus adefovir induce strong cccDNA decline and HBsAg reduction in patients with chronic hepatitis B

Karsten Wursthorn, Marc Lütgehetmann, Maura Dandri et al. · Hepatology · 2006 · 438 citations · Full text

Safety and efficacy of adefovir dipivoxil in patients infected with lamivudine-resistant hepatitis B and HIV-1

Yves Benhamou, Vincent Thibault, Pamela Vig et al. · Journal of Hepatology · 2005 · 81 citations · Full text

, , +11

FIERCE-22: Clinical activity of vofatamab (V) a FGFR3 selective inhibitor in combination with pembrolizumab (P) in WT metastatic urothelial carcinoma, preliminary analysis.

Arlene O. Siefker‐Radtke, Graeme Currie, Esteban Abella et al. · Journal of Clinical Oncology · 2019 · 64 citations

, , +20

Fierce-21: Phase II study of vofatmab (B-701), a selective inhibitor of FGFR3, as salvage therapy in metastatic urothelial carcinoma (mUC).

Andrea Necchi, Daniel Castellano, Begoña Mellado et al. · Journal of Clinical Oncology · 2019 · 43 citations

, , +18

Rows per page

1–5 of 8